Labcorp Drug Development, formerly called Covance, is a contract research organization with 20 global sites in 8 countries, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical, biotechnology, Medical device, crop protection and chemical industries.

Comprehensive nonclinical portfolio of solutions include but not limited to:
Discovery, Pharmacology models, preclinical oncology models, Non GLP and GLP studies, GLP & GCP Bioanalysis support (LC MSMS, Immunoassays, Flow), Drug Metabolism & Pharmacokinetics (DMPK), modelling & Pharmacometrics, Toxicology Studies, Development and reproductive Toxicology (DART), Safety Pharmacology, Genetic Toxicology, New approach methodologies(NAMs), SEND Services, CTA/IND enabling work, Regulatory Consulting and Project Management, CMC Analytical testing, Medical device testing, Central Lab Service, Market place - exclusive digital partnering platform.